The role of modulators in cystic fibrosis related diabetes by Lina Merjaneh, Sana Hasan, Nader Kasim, Katie Larson Ode

Subjects: Get full text

The Expression of Affective Temperaments in Cystic Fibrosis Patients: Psychopathological Associations and Possible Neurobiological Mechanisms by Andrea Amerio, Luca Magnani, Carlo Castellani, Irene Schiavetti, Gabriele Sapia, Francesca Sibilla, Rita Pescini, Rosaria Casciaro, Federico Cresta, Andrea Escelsior, Alessandra Costanza, Andrea Aguglia, Gianluca Serafini, Mario Amore, Riccardo Ciprandi

Subjects: Get full text

Sinus Disease Grading on Computed Tomography Before and After Modulating Therapy in Adult Patients with Cystic Fibrosis by Corrado Tagliati, Stefano Pantano, Giuseppe Lanni, Davide Battista, Matteo Marcucci, Marco Fogante, Giulio Argalia, Enrico Paci, Gabriella Lucidi Pressanti, Mingliang Ying, Pietro Ripani

Subjects: Get full text

Tezacaftor/Ivacaftor therapy has negligible effects on the cystic fibrosis gut microbiome by Ryan Marsh, Claudio Dos Santos, Liam Hanson, Christabella Ng, Giles Major, Alan R. Smyth, Damian Rivett, Christopher van der Gast

Subjects: Get full text

Comparison of Reporting Quality in National Cystic Fibrosis Patient Registries: Implications for Identifying Use of Novel CFTR Modulators by Owen W. Tomlinson, Philip Mitchelmore, Craig A. Williams

Subjects: “…Modulator therapy…”
Get full text

Lung Transplantation in a New Era in the Field of Cystic Fibrosis by Wei Huang, Alexander T. Smith, Maksim Korotun, Aldo Iacono, Janice Wang

Subjects: Get full text

Cystic fibrosis pathogens persist in the upper respiratory tract following initiation of elexacaftor/tezacaftor/ivacaftor therapy by Yasmin Hilliam, Catherine R. Armbruster, Glenn J. Rapsinski, Christopher W. Marshall, John Moore, Junu Koirala, Leah Krainz, Jordan R. Gaston, Vaughn S. Cooper, Stella E. Lee, Jennifer M. Bomberger

Subjects: Get full text

Increasing incidence rate of breast cancer in cystic fibrosis - relationship between pathogenesis, oncogenesis and prediction of the treatment effect in the context of worse clinic... by Nela Stastna, Kristian Brat, Lukas Homola, Audun Os, Dagmar Brancikova

Subjects: Get full text

Chronic Rhinosinusitis with Nasal Polyposis in People with Cystic Fibrosis by Jessa E. Miller, Jennifer L. Taylor-Cousar, Daniel M. Beswick

Subjects: “…highly effective modulator therapy…”
Get full text

Editorial: Mechanisms of action of small molecules on CFTR mutants and the impact on cystic fibrosis pathogenesis by Camille Ehre, Camille Ehre, Camille Ehre, Miquéias Lopes-Pacheco, Miquéias Lopes-Pacheco, Onofrio Laselva

Subjects: Get full text

Mechanistic analysis and significance of sphingomyelinase‐mediated decreases in transepithelial CFTR currents in nHBEs by Kirsten A. Cottrill, Vincent D. Giacalone, Camilla Margaroli, Robert J. Bridges, Michael Koval, Rabindra Tirouvanziam, Nael A. McCarty

Subjects: Get full text

Regulatory T cell enhancement in adults with cystic fibrosis receiving Elexacaftor/Tezacaftor/Ivacaftor therapy by Dirk Westhölter, Jonas Raspe, Hendrik Uebner, Johannes Pipping, Mona Schmitz, Svenja Straßburg, Sivagurunathan Sutharsan, Matthias Welsner, Christian Taube, Sebastian Reuter

Subjects: Get full text

Changes in the Cystic Fibrosis Airway Microbiome in Response to CFTR Modulator Therapy by Buqing Yi, Alexander H. Dalpke, Sébastien Boutin, Sébastien Boutin

Subjects: Get full text

Changes in vitamins and trace elements after initiation of highly effective CFTR modulator therapy in children and adults with cystic fibrosis – a real-life insight by Dorit Fabricius, Tina Knieling, Noelle Zurmuehl, Leandra Makedon, Joachim Freihorst, Hanna Schmidt, Sebastian Bode

Subjects: “…Highly effective CFTR modulator therapy…”
Get full text

Prevalence and characteristics of gastrointestinal disorders, medication use, and diagnostic interventions in pediatric patients with cystic fibrosis: a nested case–control analysi... by Carolena Trocchia, Carolena Trocchia, Maua Mosha, Bailey Hamner, Neil Goldenberg, Racha Khalaf

Subjects: Get full text

Intestinal current measurement detects age-dependent differences in CFTR function in rectal epithelium by Simon Y. Graeber, Simon Y. Graeber, Simon Y. Graeber, Olaf Sommerburg, Olaf Sommerburg, Yin Yu, Yin Yu, Julian Berges, Julian Berges, Stephanie Hirtz, Heike Scheuermann, Jasmin Berger, Jasmin Berger, Jasmin Berger, Julia Duerr, Julia Duerr, Julia Duerr, Marcus A. Mall, Marcus A. Mall, Marcus A. Mall

Subjects: Get full text

Body composition changes and clinical outcomes in pediatric cystic fibrosis during 24 months of lumacaftor ivacaftor therapy based on real-world data by Marcell Imrei, Adrienn F. Kéri, Éva Gács, Ildikó Gönczi, Melinda Meláth, Éva Kosaras, Botond Demeter, Csaba Péterfia, Klára Vass, Gyöngyi Székely, Klementina Ocskay, Andrea Párniczky

Subjects: Get full text

Early and sustained improvements of lung clearance index from two to sixteen weeks of elexacaftor/tezacaftor/ivacaftor therapy in patients with cystic fibrosis—a real world study by Dorothea Appelt, Gratiana Steinkamp, Sarah Sieber, Helmut Ellemunter

Subjects: Get full text

Multimodal analysis of granulocytes, monocytes, and platelets in patients with cystic fibrosis before and after Elexacaftor–Tezacaftor–Ivacaftor treatment by Hanna Schmidt, Larissa Melina Höpfer, Lisa Wohlgemuth, Christiane Leonie Knapp, Adam Omar Khalaf Mohamed, Laura Stukan, Frederik Münnich, Dominik Hüsken, Alexander Sebastian Koller, Alexander Elias Paul Stratmann, Paul Müller, Christian Karl Braun, Christian Karl Braun, Christian Karl Braun, Dorit Fabricius, Sebastian Felix Nepomuk Bode, Markus Huber-Lang, David Alexander Christian Messerer, David Alexander Christian Messerer

Subjects: Get full text

Future Comorbidities in an Aging Cystic Fibrosis Population by Javier Humberto Ticona, Nicole Lapinel, Janice Wang

Subjects: “…highly effective modulator therapy (HEMT)…”
Get full text